Joe Betts-LaCroix

Last updated
Joe Betts-LaCroix
JoeTED 2.png
Joe Betts-LaCroix in 2011
Born (1962-02-26) February 26, 1962 (age 62)
Alma mater Harvard College
OccupationCEO of Retro Biosciences
Website evocator.org

Jonathan "Joe" Betts-LaCroix (born Jonathan Betts February 26, 1962) is an American scientist and entrepreneur known for his discoveries in biophysics and for creating the world's smallest personal computer. He is working to optimize medical research priorities in the U.S.

Contents

Early life and education

Joe Betts-LaCroix was born and raised in Oregon. He graduated from the school with "D average", and "spent the next six years living in a shared house with 'musicians, artists and weirdos'". He did some "electronics, hardware and software work for local businesses" at this time. When his girlfriend went to Harvard, he decided to follow, and after getting "straight A's" at a local college, he then transferred to Harvard, where he studied environmental geoscience. [1]

Academics

Beginning in earth sciences at Harvard, Betts-LaCroix contributed to the field of long-term regulation of oxygen on Earth over multi-100 Million-year timespans, quantifying the effect of the burial efficiency of organic carbon as a feedback mechanism. [2]

At MIT, he designed and built an autonomous, robotic system that enables research into ocean circulation patterns and climate change, by operating untended for up to one year at sea on battery power and collecting hyper-pure water samples at predetermined intervals. [3]

In work at Caltech, Betts-LaCroix moved into biophysics, publishing a paper in Science that has been cited by more than 700 subsequent scientific works. [4] In this work, he, along with David Beratan and José Onuchic,proved for the first time that electron-transfer rates in proteins are determined by the electron orbital interactions in the protein structure. [5]

Hardware

In 2000, Betts-LaCroix cofounded OQO, a computer hardware and software OEM credited by the Guinness World Records as having created the world's smallest Windows PC. [6] This created a new category of mobile computing devices between PDAs and laptops, which were initially dubbed the "Ultra Personal Computer", and which subsequently became known as the "Netbook". The device won many awards for its innovation, aesthetics and functionality. [7] [8] [9] [10] [11]

After OQO, Betts-Lacroix was active in Silicon Valley as a lecturer and mentor for CEOs of start up companies. [12]

Biotechnology & biomedicine

Betts-LaCroix has participated in the Quantified Self movement since the beginning, [13] and has given numerous presentations on aspects of self experimentation and tracking, including experiments in the 28-Hour day. [14]

In 2010, he joined startup Halcyon Molecular to lead its automation efforts. [15] Halcyon, funded by, among others, Elon Musk and Peter Thiel, attempted to sequence human DNA using electron microscopes. The underlying goal of Halcyon's work was to make meaningful progress in understanding human biology in order to improve medicine. [15]

Following the theme of improving medicine, Betts-LaCroix founded the Health Extension Foundation in 2012. [16] The efforts of the people working in Health Extension are motivated by recognizing that

  1. Most healthcare money treats age-related diseases;
  2. Aging is the single biggest risk factor for these diseases;
  3. But funding to address the biochemical processes of aging is less than 0.01% of healthcare spending—and correcting this missed opportunity to optimally assign medical research and translation priorities. [17]

In 2013, Betts-LaCroix cofounded Vium, which has raised $33M to accelerate the development of new medical therapies by automating in-vivo research. [18] [19] Vium launched publicly in 2016, [20] and was later acquired by Recursion in 2020. [21]

Betts-LaCroix is also a biotech angel investor in such companies as StemCentrx, Recursion Pharma [22] and Spring Discovery, [23] as well as a part-time contributor at Y Combinator. [24]

In 2020, Betts-LaCroix cofounded Retro Biosciences, which emerged out of stealth with $180 million in funding from OpenAI CEO Sam Altman [25] to focus on extending healthy human lifespans. [26] Retro works on autophagy, the rejuvenation of blood plasma and on partial cell reprogramming. [1]

See also

Related Research Articles

<span class="mw-page-title-main">Structural biology</span> Study of molecular structures in biology

Structural biology, as defined by the Journal of Structural Biology, deals with structural analysis of living material at every level of organization.

<span class="mw-page-title-main">Michael Bloomberg</span> American businessman and politician (born 1942)

Michael Rubens Bloomberg is an American businessman and politician. He is the majority owner and co-founder of Bloomberg L.P., and was its CEO from 1981 to 2001 and again from 2014 to 2023. He served as the mayor of New York City for three terms from 2002 to 2013 and was a candidate for the 2020 Democratic nomination for president of the United States. In 2024, Bloomberg received the Presidential Medal of Freedom from President Joe Biden. He has served as chair of the Defense Innovation Board, an independent advisory board that provides recommendations on artificial intelligence, software, data and digital modernization to the United States Department of Defense, since June 2022.

<span class="mw-page-title-main">Cytochrome c oxidase</span> Complex enzyme found in bacteria, archaea, and mitochondria of eukaryotes

The enzyme cytochrome c oxidase or Complex IV is a large transmembrane protein complex found in bacteria, archaea, and the mitochondria of eukaryotes.

Combinatory logic is a notation to eliminate the need for quantified variables in mathematical logic. It was introduced by Moses Schönfinkel and Haskell Curry, and has more recently been used in computer science as a theoretical model of computation and also as a basis for the design of functional programming languages. It is based on combinators, which were introduced by Schönfinkel in 1920 with the idea of providing an analogous way to build up functions—and to remove any mention of variables—particularly in predicate logic. A combinator is a higher-order function that uses only function application and earlier defined combinators to define a result from its arguments.

In combinatory logic for computer science, a fixed-point combinator, is a higher-order function that returns some fixed point of its argument function, if one exists.

<span class="mw-page-title-main">Metalloprotein</span> Protein that contains a metal ion cofactor

Metalloprotein is a generic term for a protein that contains a metal ion cofactor. A large proportion of all proteins are part of this category. For instance, at least 1000 human proteins contain zinc-binding protein domains although there may be up to 3000 human zinc metalloproteins.

<span class="mw-page-title-main">Nitric oxide</span> Colorless gas with the formula NO

Nitric oxide is a colorless gas with the formula NO. It is one of the principal oxides of nitrogen. Nitric oxide is a free radical: it has an unpaired electron, which is sometimes denoted by a dot in its chemical formula. Nitric oxide is also a heteronuclear diatomic molecule, a class of molecules whose study spawned early modern theories of chemical bonding.

<span class="mw-page-title-main">Air ioniser</span> ION is mostly used on air conditioning products. Ioniser is another word for air purifier

An air ioniser is a device that uses high voltage to ionise air molecules. Negative ions, or anions, are particles with one or more extra electrons, conferring a net negative charge to the particle. Cations are positive ions missing one or more electrons, resulting in a net positive charge. Some commercial air purifiers are designed to generate negative ions. Another type of air ioniser is the electrostatic discharge (ESD) ioniser used to neutralise static charge.

<span class="mw-page-title-main">Peter Agre</span> American physician (born 1949)

Peter Agre is an American physician, Nobel Laureate, and molecular biologist, Bloomberg Distinguished Professor at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine, and director of the Johns Hopkins Malaria Research Institute. In 2003, Agre and Roderick MacKinnon shared the 2003 Nobel Prize in Chemistry for "discoveries concerning channels in cell membranes." Agre was recognized for his discovery of aquaporin water channels. Aquaporins are water-channel proteins that move water molecules through the cell membrane. In 2009, Agre was elected president of the American Association for the Advancement of Science (AAAS) and became active in science diplomacy.

In chemistry, a non-covalent interaction differs from a covalent bond in that it does not involve the sharing of electrons, but rather involves more dispersed variations of electromagnetic interactions between molecules or within a molecule. The chemical energy released in the formation of non-covalent interactions is typically on the order of 1–5 kcal/mol. Non-covalent interactions can be classified into different categories, such as electrostatic, π-effects, van der Waals forces, and hydrophobic effects.

<span class="mw-page-title-main">Photosynthetic reaction centre</span> Molecular unit responsible for absorbing light in photosynthesis

A photosynthetic reaction center is a complex of several proteins, biological pigments, and other co-factors that together execute the primary energy conversion reactions of photosynthesis. Molecular excitations, either originating directly from sunlight or transferred as excitation energy via light-harvesting antenna systems, give rise to electron transfer reactions along the path of a series of protein-bound co-factors. These co-factors are light-absorbing molecules (also named chromophores or pigments) such as chlorophyll and pheophytin, as well as quinones. The energy of the photon is used to excite an electron of a pigment. The free energy created is then used, via a chain of nearby electron acceptors, for a transfer of hydrogen atoms (as protons and electrons) from H2O or hydrogen sulfide towards carbon dioxide, eventually producing glucose. These electron transfer steps ultimately result in the conversion of the energy of photons to chemical energy.

<span class="mw-page-title-main">Harry B. Gray</span> American inorganic chemist

Harry Barkus Gray is the Arnold O. Beckman Professor of Chemistry at California Institute of Technology.

<span class="mw-page-title-main">Bacterial nanowires</span> Electrically conductive appendages produced by a number of bacteria

Bacterial nanowires are electrically conductive appendages produced by a number of bacteria most notably from the Geobacter and Shewanella genera. Conductive nanowires have also been confirmed in the oxygenic cyanobacterium Synechocystis PCC6803 and a thermophilic, methanogenic coculture consisting of Pelotomaculum thermopropionicum and Methanothermobacter thermoautotrophicus. From physiological and functional perspectives, bacterial nanowires are diverse. The precise role microbial nanowires play in their biological systems has not been fully realized, but several proposed functions exist. Outside of a naturally occurring environment, bacterial nanowires have shown potential to be useful in several fields, notably the bioenergy and bioremediation industries.

Dilan Jayawardane is a Sri Lankan engineer who co-founded Scoopler based in the United States.

Peter Leslie Dutton FRS is a British biochemist, and Eldridge Reeves Johnson Professor of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania. He is a 2013 recipient of the John Scott Award for his work on electron transfer, studying the organization of electrons in cells and the mechanisms by which they convert light or oxygen into energy for the cell.

Calico Life Sciences LLC is an American biotechnology company with a focus on the biology of aging, attempting to devise interventions that may enable people to lead longer and healthier lives. It is a subsidiary of Alphabet Inc.

<span class="mw-page-title-main">Michael Seibel</span> Managing director at Y Combinator

Michael Seibel is a partner at Y Combinator and co-founder of two startups – Justin.tv/Twitch and Socialcam. He first joined Y Combinator in 2013, advising hundreds of startups, and has been active in promoting diversity efforts among startup founders.

David N. Beratan is an American chemist and physicist, the R.J. Reynolds Professor of Chemistry at Duke University. He has secondary appointments in the departments of Physics and Biochemistry. He is the director of the Center for Synthesizing Quantum Coherence, a NSF Phase I Center for Chemical Innovation.

<span class="mw-page-title-main">Bisantrene</span> Chemical compound

Bisantrene is an anthracenyl bishydrazone with anthracycline-like antineoplastic activity and an antimetabolite. Bisantrene intercalates with and disrupts the configuration of DNA, resulting in DNA single-strand breaks, DNA-protein crosslinking, and inhibition of DNA replication. This agent is similar to doxorubicin in chemotherapeutic activity, but unlike anthracyclines like doxorubicin, it exhibits little cardiotoxicity.

Jory Bell is an American executive who is a general partner at Playground Global, a venture capital firm based in Palo Alto, California. He joined the firm in 2015 as vice president and has been involved in investments in deep tech areas such as advanced manufacturing, aerospace, genomics, and synthetic/computational biology.

References

  1. 1 2 "The Most Secretive Longevity Lab Finally Opens Its Doors". Bloomberg.com. 19 December 2023. Retrieved 20 December 2023.
  2. Betts, Jonathan (1991). "The oxygen content of ocean bottom waters, the burial efficiency of organic carbon, and the regulation of atmospheric oxygen". Palaeogeography, Palaeoclimatology, Palaeoecology. 97 (1–2): 5–18. Bibcode:1991PPP....97....5B. doi:10.1016/0031-0182(91)90178-T. PMID   11538093.
  3. Bell, Jory (2002). "MITESS: a moored in situ trace element serial sampler for deep-sea moorings". Deep Sea Research Part I: Oceanographic Research Papers. 49 (11): 2103–2118. Bibcode:2002DSRI...49.2103B. doi:10.1016/S0967-0637(02)00126-7.
  4. "Google Scholar citations" . Retrieved 22 April 2018.
  5. Beratan, DN (1991). "Protein electron transfer rates set by the bridging secondary and tertiary structure". Science. 252 (5010): 1285–1288. Bibcode:1991Sci...252.1285B. doi:10.1126/science.1656523. PMID   1656523 . Retrieved 18 June 2013.
  6. Guinness Book of World Records 2006, ISBN   978-0-553-58906-1
  7. "OQO Model 2+ wins Popular Mechanics Editor's Choice Award" . Retrieved 18 June 2013.
  8. "Business 2.0 Editors' Choice: OQO" . Retrieved 18 June 2013.
  9. "PopSci's Best Of CES: OQO Model 02". 18 January 2007. Retrieved 18 June 2013.
  10. "OQO Wins The Stevie Award – 2008 Best Product". 2008-06-23. Retrieved 18 June 2013.
  11. "OQO Wins Japans 2007 Good Design Award". 2007-11-13. Retrieved 18 June 2013.
  12. "Startup Company Lawyer". 4 May 2009. Retrieved 18 June 2013.
  13. "First Meeting of The Quantified Self Meetup Group" . Retrieved 18 June 2013.
  14. "Quantified Self: Joe Betts-LaCroix on the 28-Hour Day". Quantified Self. 2011-09-22. Retrieved 18 June 2013.
  15. 1 2 "VentureBeat: Genome Entrepreneurs". 2012-04-21. Retrieved 18 June 2013.
  16. "Oakland Futurist: Health Extension Salon". 2013-01-26. Retrieved 18 June 2013.
  17. "Health Extension: Mission" . Retrieved 18 June 2013.
  18. "Bloomberg Businessweek: Building a Better Mouse Cage". Bloomberg News . Retrieved 29 January 2017.
  19. "BioCentury: Digital Preclinical" . Retrieved 29 January 2017.
  20. "Xconomy: Silicon Valley Vets Aim to Shake Up Preclinical Testing With Vium". 2016-06-02. Retrieved 29 January 2017.
  21. "Recursion Acquires Vium Bolstering Its Efforts to Industrialize Drug Discovery". 28 July 2020. Retrieved 21 July 2021.
  22. "Joe Betts-LaCroix - Angel List" . Retrieved 22 April 2018.
  23. "Spring Discovery Raises $4.25M in Seed Funding". 2018-02-26. Retrieved 22 April 2018.
  24. Y Combinator's Summer Reading List 2017 . Retrieved 22 April 2018.
  25. "Sam Altman invested $180 million into a company trying to delay death". MIT Technology Review. 8 March 2023.
  26. "Retro Biosciences Raises $180 Million With Goal of Extending Lifespan By 10 Years" . Retrieved 12 April 2022.